Alan Xiangdong Wang
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Asymmetric Synthesis and Catalysis
Most-Cited Works
- → The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2014)110 cited
- → Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2014)66 cited
- → Potent Inhibitors of Hepatitis C Virus NS3 Protease: Employment of a Difluoromethyl Group as a Hydrogen-Bond Donor(2018)40 cited
- → Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing(2016)30 cited
- → Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold(2023)23 cited
- → P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor(2018)8 cited
- → Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus(2016)5 cited
- → Improved Synthesis of 1-Chloro-6-methoxy-isoquinolin-3-ol and Its Derivatives(2009)4 cited
- → ChemInform Abstract: Improved Synthesis of 1‐Chloro‐6‐methoxy‐isoquinolin‐3‐ol and Its Derivatives.(2009)
- → CCDC 984481: Experimental Crystal Structure Determination(2014)